Durairaj Sekar

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Top Venues

Molecules (Basel, Switzerland)

Biomarkers in medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ameya Kp, Kumaravel Kaliaperumal, Durairaj Sekar
microRNAs and their therapeutic strategy in phase I and phase II clinical trials. Epigenomics 16 (4) (2024)
Ameya Kp, Kumaravel Kaliaperumal, Durairaj Sekar
microRNAs and their therapeutic strategy in phase I and phase II clinical trials. Epigenomics (2024)
Ameya Kp, Kumaravel Kaliaperumal, Durairaj Sekar
microRNAs and their therapeutic strategy in phase I and phase II clinical trials. Epigenomics 16 (4) (2024)
Jenifer Mallavarpu Ambrose, Kullappan Malathi, Shankaragouda Patil, Khalid J Alzahrani, Hamsa Jameel Banjer, Fadi S I Qashqari, A Thirumal Raj, Shilpa Bhandi, Vishnu Priya Veeraraghavan, Jayaraman Selvaraj, Durairaj Sekar, Alok Agarwal, Korla Swapnavahini, Surapaneni Krishna Mohan
Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach. Molecules (Basel, Switzerland) 27 (6) (2022)
Monisha Prasad, Selvaraj Jayaraman, Mohamed Ahmed Eladl, Mohamed El Sherbiny, Mosaab Abdella Ebrahim Abdelrahman, Vishnu Priya Veeraraghavan, Srinivasan Vengadassalapathy, Vidhya Rekha Umapathy, Shazia Fathima Jaffer Hussain, Kalaiselvi Krishnamoorthy, Durairaj Sekar, Chella Perumal Palanisamy, Surapaneni Krishna Mohan, Ponnulakshmi Rajagopal
A Comprehensive Review on Therapeutic Perspectives of Phytosterols in Insulin Resistance: A Mechanistic Approach. Molecules (Basel, Switzerland) 27 (5) (2022)
Durairaj Sekar
miRNA 21: a novel biomarker in the treatment of bladder cancer. Biomarkers in medicine 14 (12) (2021)
K Auxzilia Preethi, Ganesh Lakshmanan, Durairaj Sekar
Antagomir technology in the treatment of different types of cancer. Epigenomics 13 (7) (2021)
K Auxzilia Preethi, Durairaj Sekar
Dietary microRNAs: Current status and perspective in food science. Journal of food biochemistry 45 (7) (2021)
George Bibby, Blerta Krasniqi, Izaak Reddy, Durairaj Sekar, Kehinde Ross
Capturing the RNA castle: Exploiting MicroRNA inhibition for wound healing. The FEBS journal (2021)
Durairaj Sekar, Auxzilia Preethi K
Letter to the Editor: H19 Promotes HCC Bone Metastasis by Reducing Osteoprotegerin Expression in a PPP1CA/p38MAPK-Dependent Manner and Sponging miR-200b-3p. Hepatology (Baltimore, Md.) 74 (3) (2021)
Durairaj Sekar
Implications of microRNA 21 and its involvement in the treatment of different type of arthritis. Molecular and cellular biochemistry 476 (2) (2020)
Durairaj Sekar, Ganesh Lakshmanan, Biruntha M
Implications of CRISPR/Cas9 system in Hypertension and its related diseases. Journal of human hypertension 35 (7) (2020)
Durairaj Sekar, Ganesh Lakshmanan
Methylation of N6-adenosine (m6A) modification in miRNAs and its implications in immunity. Epigenomics 12 (13) (2020)
Srivathchava Selvaraj, Ganesh Lakshmanan, Kohila Kalimuthu, Durairaj Sekar
Role of microRNAs and their involvement in preeclampsia. Epigenomics 12 (20) (2020)